Article Details

Here's What This Label Expansion Means for AstraZeneca Investors | The Motley Fool

Retrieved on: 2021-08-17 11:15:00

Tags for this article:

Click the tags to see associated articles and topics

Here's What This Label Expansion Means for AstraZeneca Investors | The Motley Fool. View article details on hiswai:

Excerpt

The EMA's approval of Forxiga for chronic kidney disease gives AstraZeneca access to millions of patients in the EU. Forxiga's efficacy and this massive ...

Article found on: www.fool.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up